Concomitant versus sequential gemcitabine (G) and docetaxel (D) as first-line chemotherapy in advanced non-small-cell lung cancer (NSCLC):: updated outcomes and quality of life (QoL) results of a Phase II/III randomised study

被引：0
|
作者：
Thatcher, N
Manegold, C
Kortsik, C
Koschel, G
Spengler, W
Mezger, J
Müller, A
Pilz, LR
机构：
[1] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England
[2] Univ Med Ctr, Mannheim, Germany
[3] KH Sankt Hildegardis, Catholic Clin Ctr Mainz, Mainz, Germany
[4] AKH Hamburg, Hamburg, Germany
[5] KH Schillerhohe, Gerlingen, Germany
[6] St Vincentius Kliniken, Med Klin, Karlsruhe, Germany
[7] Thoraxklin, Heidelberg, Germany
[8] German Canc Res Ctr, D-6900 Heidelberg, Germany
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [1] Sequential versus concomitant administration of docetaxel and gemcitabine as first-line treatment of advanced non-small cell lung cancer (NSCLC):: results of a phase II/III randomised study
    Manegold, C.
    Thatcher, N.
    Kortsik, C.
    Koschel, G.
    Spengler, W.
    Mezgar, J.
    Schott von Romer, K.
    Pilz, L.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 326 - 326
  • [2] A phase II/III randomized study in advanced non-small-cell lung cancer (NSCLC) with first-line combination versus sequential gemcitabine and docetaxel:: second interim study results
    Müller, A
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Pitz, LR
    Mezger, J
    Manegold, C
    [J]. LUNG CANCER, 2004, 45 : S76 - S76
  • [3] First-line chemotherapy with planned sequential administration of gemcitabine (G) followed by docetaxel (D) in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study
    Vasile, E.
    Tibaldi, C.
    Antonuzzo, A.
    Di Marsico, R.
    Tartarelli, G.
    Fabbri, A.
    Lo Dico, M.
    Mazzoni, E.
    Andreuccetti, M.
    Falcone, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine (G) and docetaxel (D):: Update on quality of life (QoL), toxicity, and costs.
    Manegold, C
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Mezger, J
    Müller, A
    Pilz, LR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 634S - 634S
  • [5] First-line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: a multicenter phase II study
    Tibaldi, C.
    Vasile, E.
    Lo Dico, M.
    Antonuzzo, A.
    Di Marsico, R.
    Tartarelli, G.
    Fabbri, A.
    Mazzoni, E.
    Andreuccetti, M.
    Falcone, A.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 176 - 176
  • [6] Gemcitabine and docetaxel as concomitant or sequential first-line therapy of advanced non-small cell lung cancer:: Updated results of a randomized study
    Manegold, C
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Mezger, J
    Müller, A
    Piiz, L
    [J]. LUNG CANCER, 2005, 49 : S36 - S36
  • [7] A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first-line combination versus sequential gemcitabine and docetaxel: second interim study results
    Mueller, Annette
    Thatcher, Nick
    Kortsik, Cornelius
    Koschel, Gabriele
    Spengler, Werner
    Pitz, Lothar R.
    Mezger, Joerg
    Manegold, Christian
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 168 - 169
  • [8] A new docetaxel (D) gemcitabine (G) regimen as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): A phase II study.
    Morere, JF
    Terrioux, P
    Brechot, JM
    Tredaniel, J
    Bouchahda, M
    Duhamel, JP
    Mandet, J
    Brain, E
    Beerblock, K
    Fellague, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 692S - 692S
  • [9] First line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study
    Lo Dico, M.
    Vasile, E.
    Tibaldi, C.
    Antonuzzo, A.
    Di Marsico, R.
    Tartarelli, G.
    Fabbri, A.
    Mazzoni, E.
    Andreuccetti, M.
    D'Alessandro, M.
    Nacci, A.
    Falcone, A.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 35 - 35
  • [10] A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results.
    Mueller, A
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Pilz, L
    Mezger, J
    Manegold, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 640S - 640S
12345